Antibiotics market size will reach USD 63 billion by 2030


LOS ANGELES, Sept. 21, 2022 (GLOBE NEWSWIRE) — The Global Antibiotics market The size accounted for USD 42 billion in 2021 and is expected to generate a market size of USD 63 billion by 2030, growing at a CAGR of 4.6% from 2022 to 2030.

Highlights of the Antibiotics Market Report

  • The global antibiotics market value was USD 42 billion in 2021 and is expected to grow at a CAGR of 4.6% from 2022 to 2030
  • According to the University of Oxford, global antibiotic consumption rates increased by 46% between 2000 and 2018
  • Antibiotics Market Share in Asia-Pacific Acquired Over 45% Market Share in the Coming Years
  • Asia-Pacific Antibiotics Market Growth Recorded Fastest CAGR During Forecast Period 2022 to 2030
  • Among product types, penicillin acquired more than 28% of the overall market share in 2021

Free Sample Report Request @

Report cover:

Market Antibiotics market
Antibiotics market Size 2021 $42 billion
Antibiotics market Forecast 2030 $63 billion
Antibiotics market CAGR from 2022 to 2030 4.6%
Antibiotics market Analysis period 2018 – 2030
Antibiotics market base year 2021
Antibiotics market Forecast data 2022 – 2030
Segments Covered By product type, by drug origin, by spectrum, by route of administration, by distribution channel and by geography
Antibiotics market Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Profiled Key Companies Abbott Laboratories, Allergan plc, Basilea Pharmaceutica Ltd., Bayer Healthcare AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson Inc., Melinta Therapeutics, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi SA and Tetraphase Pharmaceuticals.
Report cover Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulatory Analysis

Antibiotics Market Dynamics

During the forecast period from 2022 to 2030, the global antibiotics market is expected to grow the fastest. Antibacterial agents are another name for antibiotics. These are mainly developing due to the increasing incidence of infectious diseases. Continuous efforts by pharmaceutical companies to develop new treatments to treat infectious diseases are helping to drive the growth of the market.

Some of the key observations regarding the antibiotic industry include

  • In 2021, an Australian study found that commonly used non-nutritive sugar substitutes can promote the uptake of antibiotic resistance genes in the gut. Artificial sweeteners accelerate the transfer of antibiotic resistance genes (ARGs) through a process known as mating. The genes are transferred from the donor bacterium to the recipient bacterium, which can then develop multidrug resistance.
  • According to the US Centers for Disease Control and Prevention (CDC), up to 90% of antibiotics are prescribed to outpatients. Social norms and behavioral factors strongly influence outpatient antibiotic prescribing. Antimicrobial resistance (AMR) and the requirement for antimicrobial stewardship is driven by inappropriate use of 50% of outpatient antibiotics and unnecessary use of 30%, resulting in antimicrobial resistance (AMR) and the Antimicrobial Stewardship (AMS) requirement. Upper respiratory tract infections (URTIs) are, in turn, one of the most common causes of antibiotic overuse in the community.

View the report’s detailed table of contents @

Antibiotics market segmentation

The global antibiotics market is divided into four sections: product type, spectrum, drug origin, route of administration, and geography. Cephalosporins, fluoroquinolones, penicillin, macrolides, aminoglycosides, carbapenems, sulfonamides and other types of products are spread in the market. Natural, synthetic and semi-synthetic drug segments are available.

The market is divided into narrow-spectrum antibiotics and spectrum-based broad-spectrum antibiotics. Antibiotics can be taken orally, intravenously or by other routes of administration. The market is studied through distribution channels including online pharmacy, hospital pharmacy, retail pharmacy, and others.

Based on Spectrum, Broad Spectrum Antibiotics segment leads the market with the highest revenue share (%), and it is expected to maintain its dominance from 2022 to 2030. The Broad Spectrum Antibiotics Advantage like these is that they can be used to treat a wide range of infectious diseases, which is particularly useful when the infectious agent (bacteria) is unknown. Aminoglycosides, 2nd and 3rd generation quinolones, cephalosporins, and some synthetic penicillins are examples of broad-spectrum antibiotics.

Antibiotics Market Regional Outlook

The global antibiotics industry is divided into five regions: North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa (MEA). Asia-Pacific is leading the market with maximum revenue share (%) and the region is also expected to maintain its dominance during the forecast period of 2022 to 2030. The high rate of consumption in the region due to easy availability and sales-friendly government policies contribute to regional market value. Increased investment and expenditure in the approval process and research funding also increases the value of the regional market. Moreover, developing economies including India and China are also expected to contribute to the region’s lucrative growth during the forecast period of 2022 to 2030.

Buy this premium research report –

Antibiotics Market Players

Some of the major antibiotic companies operating in the industry include Abbott Laboratories, Allergan plc, Bayer Healthcare AG, Basilea Pharmaceutica Ltd., F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Melinta Therapeutics, Johnson & Johnson Inc., Merck & Co., Inc., Novartis AG, Sanofi SA, Pfizer Inc. and Tetraphase Pharmaceuticals.

Questions this report answers

  • What was the market size of Antibiotics Market in 2021?
  • What will be the CAGR of the Antibiotics Market during the forecast period from 2022 to 2030?
  • Who are the key players in the Global Antibiotics Market?
  • Which region held the largest Antibiotics market share in 2021?
  • What are the key market drivers of Antibiotics Market?
  • What is the largest end-user market for antibiotics?
  • What will be the value of the antibiotics market in 2030?

Browse more research topics on health related:

The Global cio Flow Mobile C-Arm Market should grow to a CAGR around 3.5% from 2020 to 2027 and is expected to reach market value of approximately USD 4,676.5 millioniliumnot by 2027.

The Global microRNA Market should grow to a CAGR of around 13.2% from 2020 to 2027 and is expected to reach market value of approximately USD 618.6 millioniliumnot by 2027.

The Global Generic drugs market should grow to a CAGR of around 11.1% over the forecast period 2020 to 2027 and to reach approximately $627.6 billion by 2027.

About Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of information and consulting services in the information technology, investment, telecommunications, manufacturing and consumer technology markets. ARC helps investment communities, IT professionals, and business leaders make fact-based decisions about technology purchases and develop business growth strategies to compete in the marketplace . With a team of over 100 analysts and a collective industry experience of over 200 years, Acumen Research and Consulting ensures to provide a combination of industry knowledge with global and national level expertise.

For the latest update, follow us on Twitter and, LinkedIn

Contact us:

Mr. Richard Johnson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

E-mail: [email protected]


About Author

Comments are closed.